
Top Message
We are pleased to announce that we have embarked on a new chapter as a member of the NAGASE Group. The NAGASE Group has identified manufacturing capabilities within the life sciences sector as a key strategic focus, and is actively enhancing its competencies in both manufacturing and biotechnology. Leveraging our longstanding expertise in the development and production of diagnostic enzymes and pharmaceutical raw materials, we are committed to expanding our business into broader areas of life sciences and generating new value.
Furthermore, the NAGASE Group has designated “contributing to the extension of healthy life expectancy” as a material social issue. While maintaining our core business in diagnostics, we are also dedicated to the development of next-generation healthcare solutions that harness the potential of biotechnology, thereby contributing to the advancement of health and medicine.
At Nagase Diagnostics Co., Ltd., we strive to deliver innovative technologies and products through the power of biotechnology. In collaboration with our valued partners, we will continue to pursue the Group’s vision of realizing a sustainable world where people live with peace of mind. We sincerely appreciate your continued support and look forward to your expectations for the future.

July 2025
Representative Director
Nagase Diagnostics Co., Ltd.
Hironao Makise